{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T10:39:13Z","timestamp":1788691153614,"version":"build-2803163510"},"reference-count":79,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T00:00:00Z","timestamp":1657238400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nephrol."],"abstract":"<jats:p>Diuretics are commonly used in critically ill patients with acute kidney injury (AKI) and fluid overload in intensive care units (ICU), furosemide being the diuretic of choice in more than 90% of the cases. Current evidence shows that other diuretics with distinct mechanisms of action could be used with good results in patients with selected profiles. From acetazolamide to tolvaptan, we will discuss recent studies and highlight how specific diuretic mechanisms could help to manage different ICU problems,\u00a0such as loop diuretic resistance, hypernatremia, hyponatremia, or metabolic alkalosis. The current review tries to shed some light on the potential use of non-loop diuretics based on patient profile and give recommendations for loop diuretic treatment performance focused on what the intensivist and critical care nephrologist need to know based on the current evidence.<\/jats:p>","DOI":"10.3389\/fneph.2022.879766","type":"journal-article","created":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T21:13:11Z","timestamp":1657314791000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["New Insights Into Diuretic Use to Treat Congestion in the ICU: Beyond Furosemide"],"prefix":"10.3389","volume":"2","author":[{"given":"Victor Joaquin","family":"Escudero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Mercadal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Al\u00edcia","family":"Molina-And\u00fajar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaston J.","family":"Pi\u00f1eiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Cucchiari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Jacas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Carrami\u00f1ana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esteban","family":"Poch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,7,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.294.7.813","article-title":"Acute Renal Failure in Critically Ill Patients: A Multinational, Multicenter Study","volume":"294","author":"Uchino","year":"2005","journal-title":"JAMA"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)32563-2","article-title":"Acute Kidney Injury","volume":"394","author":"Ronco","year":"2019","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-015-3850-x","article-title":"Fluid Challenges in Intensive Care: The FENICE Study: A Global Inception Cohort Study","volume":"41","author":"Cecconi","year":"2015","journal-title":"Intensive Care Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa010307","article-title":"Early Goal-Directed Therapy in the Treatment of Severe Sepsis and Septic Shock","volume":"345","author":"Rivers","year":"2001","journal-title":"N Engl J Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1097\/01.CCM.0000117317.18092.E4","article-title":"Surviving Sepsis Campaign Guidelines for Management of Severe Sepsis and Septic Shock","volume":"32","author":"Dellinger","year":"2004","journal-title":"Crit Care Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-015-3822-1","article-title":"A Systematic Review and Meta-Analysis of Early Goal. Directed Therapy for Septic Shock: The ARISE, ProCESS and ProMISe Investigators","volume":"41","author":"Angus","year":"2015","journal-title":"Intensive Care Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa062200","article-title":"Comparison of Two Fluid-Management Strategies in Acute Lung Injury","volume":"354","author":"Wiedemann","year":"2006","journal-title":"N Engl J Med"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000004617","article-title":"Fluid Overload and Mortality in Adult Critical Care Patients-A Systematic Review and Meta-Analysis of Observational Studies","volume":"48","author":"Messmer","year":"2020","journal-title":"Crit Care Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/nrneph.2013.232","article-title":"Fluid Management for the Prevention and Attenuation of Acute Kidney Injury","volume":"10","author":"Prowle","year":"2014","journal-title":"Nat Rev Nephrol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s13613-018-0439-x","article-title":"Renal Failure in Critically Ill Patients, Beware of Applying (Central Venous) Pressure on the Kidney","volume":"8","author":"Chen","year":"2018","journal-title":"Ann Intensive Care"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.5005\/jp-journals-10071-23570","article-title":"Combination of Inferior Vena Cava Diameter, Hepatic Venous Flow, and Portal Vein Pulsatility Index: Venous Excess Ultrasound Score (VEXUS Score) in Predicting Acute Kidney Injury in Patients With Cardiorenal Syndrome: A Prospective Cohort Study","volume":"24","author":"Bhardwaj","year":"2020","journal-title":"Indian J Crit Care Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13089-020-00163-w","article-title":"Quantifying Systemic Congestion With Point-Of-Care Ultrasound: Development of the Venous Excess Ultrasound Grading System","volume":"12","author":"Beaubien-Souligny","year":"2020","journal-title":"Ultrasound J"},{"key":"B13","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s13054-020-2798-6","article-title":"Association Between Furosemide Administration and Outcomes in Critically Ill Patients With Acute Kidney Injury","volume":"24","author":"Zhao","year":"2020","journal-title":"Crit Care"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.08781010","article-title":"Fluid Balance, Diuretic Use, and Mortality in Acute Kidney Injury","volume":"6","author":"Grams","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"B15","article-title":"Chapter 50: Diuretics","volume-title":"Brenner and Rectos\u2019s The Kidney","author":"Ellison","year":"2012"},{"key":"B16","doi-asserted-by":"publisher","first-page":"3841","DOI":"10.3390\/ijms20153841","article-title":"Role of Carbonic Anhydrases and Inhibitors in Acid-Base Physiology: Insights From Mathematical Modeling","volume":"20","author":"Occhipinti","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1097\/CRD.0b013e31822b4939","article-title":"Acetazolamide","author":"Kassamali","year":"2011","journal-title":"Cardiol Rev"},{"key":"B18","doi-asserted-by":"publisher","first-page":"349","DOI":"10.3390\/jcm8030349","article-title":"Acetazolamide Therapy in Patients With Heart Failure: A Meta-Analysis","volume":"8","author":"Wongboonsin","year":"2019","journal-title":"J Clin Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/0002-9149(58)90121-8","article-title":"Laboratory and Clinical Observations on Ethoxzolamide (Cardrase) as a Diuretic Agent","volume":"1","author":"Moyer","year":"1958","journal-title":"Am J Cardiol"},{"key":"B20","volume-title":"Diuretic Agents: Clinical Physiology and Pharmacology","author":"Seldin","year":"1997"},{"key":"B21","article-title":"Therapeutic Uses Of Diuretic Agents","volume-title":"StatPearls","author":"Arumugham","year":"2022"},{"key":"B22","volume-title":"Cardiology Drug Guide 2010","author":"Tighe","year":"2010"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.1478","article-title":"Acetazolamide to Increase Natriuresis in Congestive Heart Failure at High Risk for Diuretic Resistance","volume":"21","author":"Verbrugge","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1097\/00007611-198706000-00016","article-title":"Alkalemia-Associated Morbidity and Mortality in Medical and Surgical Patients","volume":"80","author":"Anderson","year":"1987","journal-title":"South Med J"},{"key":"B25","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1186\/cc11323","article-title":"Acetazolamide: A Second Wind for a Respiratory Stimulant in the Intensive Care Unit","volume":"16","author":"Heming","year":"2012","journal-title":"Crit Care"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.0019","article-title":"Effect of Acetazolamide vs Placebo on Duration of Invasive Mechanical Ventilation Among Patients With Chronic Obstructive Pulmonary Disease: A Randomized Clinical Trial","volume":"315","author":"Faisy","year":"2016","journal-title":"JAMA"},{"key":"B27","article-title":"Drugs Affecting Renal Excretory Function","volume-title":"Goodman and Gilman\u2019s. The Pharmacological Basis of Therapeutics","author":"Hardman","year":""},{"key":"B28","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/S0140-6736(98)05768-7","article-title":"Increased Lipid Peroxidation in Patients With Rhabdomyolysis","volume":"353","author":"Holt","year":"1999","journal-title":"Lancet"},{"key":"B29","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1345\/aph.1R215","article-title":"Prevention of Kidney Injury Following Rhabdomyolysis: A Systematic Review","volume":"47","author":"Scharman","year":"2013","journal-title":"Ann Pharmacother"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.9742","article-title":"Role of Bicarbonates and Mannitol in Rhabdomyolysis: A Comprehensive Review","volume":"12","author":"Somagutta","year":"2020","journal-title":"Cureus"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0085029","article-title":"Intravascular Administration of Mannitol for Acute Kidney Injury Prevention: A Systematic Review and Meta-Analysis","volume":"9","author":"Yang","year":"2014","journal-title":"PLos One"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2021.07.001","article-title":"Effect of Mannitol on Kidney Function After Kidney Transplantation: A Systematic Review and Meta-Analysis","volume":"53","author":"Laar","year":"2021","journal-title":"Transplant Proc"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1007\/s12028-020-00959-7","article-title":"Guidelines for the Acute Treatment of Cerebral Edema in Neurocritical Care Patients","volume":"32","author":"Cook","year":"2020","journal-title":"Neurocrit Care"},{"key":"B34","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1007\/BF03014345","article-title":"The Effect of High-Dose Mannitol on Serum and Urine Electrolytes and Osmolality in Neurosurgical Patients","volume":"34","author":"Manninen","year":"1987","journal-title":"Can J Anaesth"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1997.409","article-title":"Mannitol Therapy Revisited (1940-1997)","volume":"52","author":"Better","year":"1997","journal-title":"Kidney Int"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V861028","article-title":"Mannitol-Induced Acute Renal Failure","volume":"8","author":"Visweswaran","year":"1997","journal-title":"J Am Soc Nephrol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1590\/S0100-879X2012007500093","article-title":"Furosemide is Associated With Acute Kidney Injury in Critically Ill Patients","volume":"45","author":"Levi","year":"2012","journal-title":"Braz J Med Biol Res"},{"key":"B38","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s13613-019-0557-0","article-title":"Impact of Furosemide on Mortality and the Requirement for Renal Replacement Therapy in Acute Kidney Injury: A Systematic Review and Meta-Analysis of Randomised Trials","volume":"9","author":"Krzych","year":"2019","journal-title":"Ann Intensive Care"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(04)00810-8","article-title":"High-Dose Furosemide for Established ARF: A Prospective, Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial","volume":"44","author":"Cantarovich","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2044.2009.06228.x","article-title":"Benefts and Risks of Furosemide in Acute Kidney Injury","volume":"65","author":"Ho","year":"2010","journal-title":"Anaesthesia"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-017-4832-y","article-title":"Prevention of Acute Kidney Injury and Protection of Renal Function in the Intensive Care Unit: Update 2017: Expert Opinion of the Working Group on Prevention, AKI Section, European Society of Intensive Care Medicine","volume":"43","author":"Joannidis","year":"2017","journal-title":"Intensive Care Med"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(86)91001-5","article-title":"Cellular Mechanism of Action of Loop Diuretics: Implications for Drug Effectiveness and Adverse Effects","volume":"57","author":"Feig","year":"1986","journal-title":"Am J Cardiol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-199408000-00017","article-title":"Continuous Infusion of Loop Diuretics in the Critically Ill: A Review of the Literature","volume":"22","author":"Martin","year":"1994","journal-title":"Crit Care Med"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1111\/anae.14038","article-title":"Continuous Infusion vs. Intermittent Bolus Injection of Furosemide in Acute Decompensated Heart Failure: Systematic Review and Meta-Analysis of Randomised Controlled Trials","volume":"73","author":"Ng","year":"2018","journal-title":"Anaesthesia"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1159\/000108641","article-title":"Frusemide Administration in Critically Ill Patients by Continuous Compared to Bolus Therapy","volume":"107","author":"Ostermann","year":"2007","journal-title":"Nephron Clin Pract"},{"key":"B46","doi-asserted-by":"publisher","first-page":"R207","DOI":"10.1186\/cc13015","article-title":"Development and Standardization of a Furosemide Stress Test to Predict the Severity of Acute Kidney Injury","volume":"17","author":"Chawla","year":"2013","journal-title":"Crit Care"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1080\/0886022X.2021.1906701","article-title":"The Furosemide Stress Test: Current Use and Future Potential","volume":"43","author":"McMahon","year":"2021","journal-title":"Ren Fail"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp090068","article-title":"Management of Loop Diuretic Resistance in the Intensive Care Unit","volume":"66","author":"Asare","year":"2009","journal-title":"Am J Health Syst Pharm"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0260312","article-title":"Diuretic Effect of Co-Administration of Furosemide and Albumin in Comparison to Furosemide Therapy Alone: An Updated Systematic Review and Meta-Analysis","volume":"16","author":"Lee","year":"2021","journal-title":"PLos One"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000005174","article-title":"Simultaneous Use of Hypertonic Saline and IV Furosemide for Fluid Overload: A Systematic Review and Meta-Analysis","volume":"49","author":"Liu","year":"2021","journal-title":"Crit Care Med"},{"key":"B51","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/MAJ.0b013e31820f10ad","article-title":"Short-Term Effects of Hypertonic Saline Solution in Acute Heart Failure and Long-Term Effects of a Moderate Sodium Restriction in Patients With Compensated Heart Failure With New York Heart Association Class III (Class C) (SMAC-HF Study)","volume":"342","author":"Paterna","year":"2011","journal-title":"Am J Med Sci"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/01.ccm.0000425149.79348.49","article-title":"Continuous Infusions of High Dose Bumetanide to Induce Diuresis in Volume Overloaded Critically Ill Cardiac and Cardiothoracic Surgery Patients","volume":"40","author":"Brandi","year":"2012","journal-title":"Crit Care Med"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1081\/JDI-200065298","article-title":"Torsemide Versus Furosemide After Continuous Renal Replacement Therapy Due to Acute Renal Failure in Cardiac Surgery Patients","volume":"27","author":"Vargas Hein","year":"2005","journal-title":"Ren Fail"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1M177","article-title":"A Comprehensive Review of the Loop Diuretics: Should Furosemide be First Line","volume":"43","author":"Wargo","year":"2009","journal-title":"Ann Pharmacother"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2021.06.009","article-title":"Diuretic Strategies in Patients With Resistance to Loop-Diuretics in the Intensive Care Unit: A Retrospective Study From the MIMIC-III Database","volume":"65","author":"C\u00f4t\u00e9","year":"2021","journal-title":"J Crit Care"},{"key":"B56","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s13054-020-2795-9","article-title":"Impact of Protocolized Diuresis for De-Resuscitation in the Intensive Care Unit","volume":"24","author":"Bissell","year":"2020","journal-title":"Crit Care"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2005.10.002","article-title":"Hypernatremia in the Neurologic Intensive Care Unit: How High is Too High","volume":"21","author":"Aiyagari","year":"2006","journal-title":"J Crit Care"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2016.11.035","article-title":"Hydrochlorothiazide in Intensive Care Unit-Acquired Hypernatremia: A Randomized Controlled Trial","volume":"38","author":"van IJzendoorn","year":"2017","journal-title":"J Crit Care"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0b013e31825b8be2","article-title":"Angiotensin-Converting Enzyme Inhibition or Mineralocorticoid Receptor Blockade do Not Affect Prevalence of Atrial Fibrillation in Patients Undergoing Cardiac Surgery","volume":"40","author":"Pretorius","year":"2012","journal-title":"Crit Care Med"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2016.06.013","article-title":"The Effect of Spironolactone on Acute Kidney Injury After Cardiac Surgery: A Randomized, Placebo-Controlled Trial","volume":"69","author":"Barba-Navarro","year":"2017","journal-title":"Am J Kidney Dis"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1001\/jama.297.12.1319","article-title":"Effects of Oral Tolvaptan in Patients Hospitalized for Worsening Heart Failure: The EVEREST Outcome Trial","volume":"297","author":"Konstam","year":"2007","journal-title":"JAMA"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa065181","article-title":"Tolvaptan, a Selective Oral Vasopressin V2-Receptor Antagonist, for Hyponatremia","volume":"355","author":"Schrier","year":"2006","journal-title":"N Engl J Med"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.12255","article-title":"Initial Experience of Use of Tolvaptan in Critically Ill Patients With Fluid Overload","volume":"40","author":"Ruiz. Ramos","year":"2015","journal-title":"J Clin Pharm Ther"},{"key":"B64","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in Patients With Heart Failure and Reduced Ejection Fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"N Engl J Med"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.051824","article-title":"Effect of Empagliflozin on Cardiovascular and Renal Outcomes in Patients With Heart Failure by Baseline Diabetes Status: Results From the EMPEROR-Reduced Trial","volume":"143","author":"Anker","year":"2021","journal-title":"Circulation"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2020071029","article-title":"Empagliflozin Inhibits Proximal Tubule NHE3 Activity, Preserves GFR, and Restores Euvolemia in Nondiabetic Rats With Induced Heart Failure","volume":"32","author":"Borges. J\u00fanior","year":"2021","journal-title":"J Am Soc Nephrol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"779","DOI":"10.3390\/jcm8060779","article-title":"Effects of Dapagliflozin on Volume Status When Added to Renin-Angiotensin System Inhibitors","volume":"8","author":"Eickhoff","year":"2019","journal-title":"J Clin Med"},{"key":"B68","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/s41581-020-00350-x","article-title":"Organ Protection by SGLT2 Inhibitors: Role of Metabolic Energy and Water Conservation","volume":"17","author":"Marton","year":"2021","journal-title":"Nat Rev Nephrol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1007\/s12630-017-1018-6","article-title":"Perioperative Implications of Sodium-Glucose Cotransporter-2 Inhibitors: A Case Series of Euglycemic Diabetic Ketoacidosis in Three Patients After Cardiac Surgery","volume":"65","author":"Lau","year":"2018","journal-title":"Can J Anaesth"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(21)00180-7","article-title":"Dapagliflozin in Patients With Cardiometabolic Risk Factors Hospitalised With COVID-19 (DARE-19): A Randomised, Double-Blind, Placebo-Controlled, Phase 3 Trial","volume":"9","author":"Kosiborod","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2024816","article-title":"Dapagliflozin in Patients With Chronic Kidney Disease","volume":"383","author":"Heerspink","year":"2020","journal-title":"N Engl J Med"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.045691","article-title":"Empagliflozin in Heart Failure: Diuretic and Cardiorenal Effects","volume":"142","author":"Griffin","year":"2020","journal-title":"Circulation"},{"key":"B73","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1002\/ejhf.2066","article-title":"Effects of Empagliflozin on Renal Sodium and Glucose Handling in Patients With Acute Heart Failure","volume":"23","author":"Boorsma","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"B74","doi-asserted-by":"publisher","first-page":"84","DOI":"10.2174\/1574886313666180226103408","article-title":"Risks Associated With SGLT2 Inhibitors: An Overview","volume":"13","author":"Singh","year":"2018","journal-title":"Curr Drug Saf"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0217911","article-title":"Patterns of Diuretic Use in the Intensive Care Unit","volume":"14","author":"McCoy","year":"2019","journal-title":"PLos One"},{"key":"B76","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1136\/gutjnl-2020-321790","article-title":"Guidelines on the Management of Ascites in Cirrhosis","volume":"70","author":"Aithal","year":"2021","journal-title":"Gut"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.03.024","article-title":"EASL Clinical Practice Guidelines for the Management of Patients With Decompensated Cirrhosis","volume":"69","year":"2018","journal-title":"J Hepatol"},{"key":"B78","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/S0140-6736(18)30840-7","article-title":"Long-Term Albumin Administration in Decompensated Cirrhosis: An Open-Label Randomized Trial","volume":"392","author":"Caraceni","year":"2018","journal-title":"Lancet"},{"key":"B79","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1016\/j.jhep.2018.08.006","article-title":"Midodrine and Albumin for Prevention of Complications of Cirrhosis in Patients in the Waiting List for Liver Transplantation. A Randomized, Multicenter, Double. Blind, Placebo-Controlled Trial","volume":"66","author":"Sola","year":"2017","journal-title":"J Hepatol"}],"container-title":["Frontiers in Nephrology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneph.2022.879766\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T21:13:15Z","timestamp":1657314795000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneph.2022.879766\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,8]]},"references-count":79,"alternative-id":["10.3389\/fneph.2022.879766"],"URL":"https:\/\/doi.org\/10.3389\/fneph.2022.879766","relation":{},"ISSN":["2813-0626"],"issn-type":[{"value":"2813-0626","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,8]]},"article-number":"879766"}}